PR Newswire Clinical TrialsOriginal article
SetPoint® System Used for First Time in Pacific Northwest to Treat Patients with Rheumatoid Arthritis in Clinical Practice
SetPoint® SystemPositive
AI Analysis
Summary
SetPoint Medical's FDA-approved SetPoint® System for rheumatoid arthritis has been deployed in the Pacific Northwest for clinical use. The neuroimmune modulation therapy continues to expand access across the United States.
Importance:3/10
Sentiment:
0.60
FDA-approvedNeuroimmune modulationRheumatoid ArthritisCommercial expansionMedical device
Read the original article
Published by PR Newswire Clinical Trials on September 16, 2026 12:00 PM
